CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on May 9, 2019
APOLLO MEDICAL HOLDINGS, Inc.
1668 S. Garfield Avenue, 2nd Floor
Alhambra, California 91801
May 9, 2019
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: | Apollo Medical Holdings, Inc. |
Registration Statement on Form S-3
Filed April 29, 2019
File No. 333-231109
VIA EDGAR
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Apollo Medical Holdings, Inc., a Delaware corporation, hereby requests the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m., Eastern Time, on May 13, 2019, or as soon thereafter as is practicable. Please call our counsel, Calvin Cheng of TroyGould PC at 310-789-1258 to provide notice of effectiveness.
Very truly yours, | |||
APOLLO MEDICAL HOLDINGS, Inc. | |||
By: | /s/ Thomas S. Lam | ||
Thomas Lam, M.D. | |||
Chief Executive Officer |